Ondancetron Effect at Vomiting Control in Head Trauma

Phase 4

• Conditions: Condition 1: head Injuries. Condition 2: head Injuries.; Intracranial injury, unspecified; Unspecified injury of head

• Registration Number: IRCT2015043012072N6
• Lead Sponsor: Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Inclusion criteria : minor head trauma; nausea and vomiting; and a triage level of 3 or higher based on emergency severity score;
exclusion criteria : hemodynamic instability; pregnancy/lactation; any neurologic deficit; restlessleg syndrome; alcohol usage; consumption of any antiemetic drugs during the 8 hours prior to admission; chemotherapy or radiotherapy; inability to complete and understand study explanations or outcome measures; allergy or previous adverse reactions to metoclopramide or ondansetron;

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea Severity. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Dystonia. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Physical Examination.;Fatigue. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Physical Examination.;Headache. Timepoint: before drug injection and 20 minutes after drug injection. Method of measurement: Visual AnalogueScale.